SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Elizabeth W. Karlson, Dirkjan van Schaardenburg, Annette H. van der Helm-van Mil, Strategies to predict rheumatoid arthritis development in at-risk populations, Rheumatology, 2016, 55, 1, 6

    CrossRef

  2. 2
    Janak L. Pathak, Astrid D. Bakker, Frank P. Luyten, Patrick Verschueren, Willem F. Lems, Jenneke Klein-Nulend, Nathalie Bravenboer, Systemic Inflammation Affects Human Osteocyte-Specific Protein and Cytokine Expression, Calcified Tissue International, 2016,

    CrossRef

  3. 3
    Annie Yarwood, Tom W. J. Huizinga, Jane Worthington, The genetics of rheumatoid arthritis: risk and protection in different stages of the evolution of RA: Table 1, Rheumatology, 2016, 55, 2, 199

    CrossRef

  4. 4
    Elizabeth V Arkema, Bing Lu, Susan Malspeis, Elizabeth W Karlson, Karen H Costenbader, Monocyte chemotactic protein-1 elevation prior to the onset of rheumatoid arthritis among women, Biomarkers in Medicine, 2015, 9, 8, 723

    CrossRef

  5. 5
    Laura Hunt, Paul Emery, Defining populations at risk of rheumatoid arthritis: the first steps to prevention, Nature Reviews Rheumatology, 2014, 10, 9, 521

    CrossRef

  6. 6
    Tabitha N. Kung, Vivian P. Bykerk, Detecting the Earliest Signs of Rheumatoid Arthritis, Rheumatic Disease Clinics of North America, 2014, 40, 4, 669

    CrossRef

  7. 7
    Anca I. Catrina, Kevin D. Deane, Jose U. Scher, Gene, environment, microbiome and mucosal immune tolerance in rheumatoid arthritis, Rheumatology, 2014, keu469

    CrossRef

  8. 8
    V. Michael Holers, Insights from Populations at Risk for the Future Development of Classified Rheumatoid Arthritis, Rheumatic Disease Clinics of North America, 2014, 40, 4, 605

    CrossRef

  9. 9
    G. Keser, H. Direskeneli, K. Aksu, Management of Takayasu arteritis: a systematic review, Rheumatology, 2014, 53, 5, 793

    CrossRef

  10. 10
    Kevin D. Deane, Hani El-Gabalawy, Pathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLE, Nature Reviews Rheumatology, 2014, 10, 4, 212

    CrossRef

  11. 11
    Kevin D. Deane, Preclinical Rheumatoid Arthritis (Autoantibodies): An Updated Review, Current Rheumatology Reports, 2014, 16, 5

    CrossRef

  12. 12
    Samina A. Turk, Marian H. van Beers-Tas, Dirkjan van Schaardenburg, Prediction of Future Rheumatoid Arthritis, Rheumatic Disease Clinics of North America, 2014, 40, 4, 753

    CrossRef

  13. 13
    M. Kristen Demoruelle, Kevin D. Deane, V. Michael Holers, When and where does inflammation begin in rheumatoid arthritis?, Current Opinion in Rheumatology, 2014, 26, 1, 64

    CrossRef

  14. 14
    Hae-Rim Kim, Anti-citrullinated protein antibodies in rheumatoid arthritis: a bridge between genetic predisposition and autoimmunity, The Korean Journal of Internal Medicine, 2013, 28, 1, 25

    CrossRef

  15. 15
    V Michael Holers, Autoimmunity to citrullinated proteins and the initiation of rheumatoid arthritis, Current Opinion in Immunology, 2013, 25, 6, 728

    CrossRef

  16. 16
    Kevin D. Deane, Can rheumatoid arthritis be prevented?, Best Practice & Research Clinical Rheumatology, 2013, 27, 4, 467

    CrossRef

  17. 17
    Else Marie Bartels, Søren Ribel-Madsen, Cytokine measurements and possible interference from heterophilic antibodies – Problems and solutions experienced with rheumatoid factor, Methods, 2013, 61, 1, 18

    CrossRef

  18. 18
    A. P. Diamantopoulos, G. Hatemi, Lack of efficacy of tocilizumab in mucocutaneous Behcet's syndrome: report of two cases, Rheumatology, 2013, 52, 10, 1923

    CrossRef

  19. 19
    Jenny Amaya-Amaya, Juan Camilo Sarmiento-Monroy, Ruben-Dario Mantilla, Ricardo Pineda-Tamayo, Adriana Rojas-Villarraga, Juan-Manuel Anaya, Novel risk factors for cardiovascular disease in rheumatoid arthritis, Immunologic Research, 2013, 56, 2-3, 267

    CrossRef

  20. 20
    M. Kristen Demoruelle, Mark C. Parish, Lezlie A. Derber, Jason R. Kolfenbach, Jan M. Hughes-Austin, Michael H. Weisman, William Gilliland, Jess D. Edison, Jane H. Buckner, Ted R. Mikuls, James R. O'Dell, Richard M. Keating, Peter K. Gregersen, Jill M. Norris, V. Michael Holers, Kevin D. Deane, Performance of Anti–Cyclic Citrullinated Peptide Assays Differs in Subjects at Increased Risk of Rheumatoid Arthritis and Subjects With Established Disease, Arthritis & Rheumatism, 2013, 65, 9
  21. 21
    H. W. Steenbergen, T. W. J. Huizinga, A. H. M. Helm-van Mil, Review: The Preclinical Phase of Rheumatoid Arthritis: What Is Acknowledged and What Needs to be Assessed?, Arthritis & Rheumatism, 2013, 65, 9
  22. 22
    David López Herráez, Manuel Martínez-Bueno, Laura Riba, Ignacio García Torre, Mónica Sacnún, Mario Goñi, Guillermo A. Berbotto, Sergio Paira, Jorge Luis Musuruana, César E. Graf, Alejandro J. Alvarellos, Osvaldo D. Messina, Alejandra M. Babini, Ingrid Strusberg, Juan Carlos Marcos, Hugo Scherbarth, Alberto J. Spindler, Ana Quinteros, Sergio M. A. Toloza, José Luis C. Moreno, Luis J. Catoggio, Guillermo Tate, Alicia Eimon, Gustavo Citera, Antonio Catalán Pellet, Gustavo G. Nasswetter, Mario H. Cardiel, Pedro Miranda, Francisco Ballesteros, Jorge A. Esquivel-Valerio, Marco A. Maradiaga-Ceceña, Eduardo M. Acevedo-Vásquez, Conrado García García, Teresa Tusié-Luna, Bernardo A. Pons-Estel, Marta E. Alarcón-Riquelme, Rheumatoid Arthritis in Latin Americans Enriched for Amerindian Ancestry Is Associated With Loci in Chromosomes 1, 12, and 13, and the HLA Class II Region, Arthritis & Rheumatism, 2013, 65, 6
  23. 23
    Lars Klareskog, Karin Lundberg, Vivianne Malmström, 2013,

    CrossRef

  24. 24
    Kevin D. Deane, Learning about the natural history of rheumatoid arthritis development through prospective study of subjects at high risk of rheumatoid arthritis–related autoimmunity, Arthritis & Rheumatism, 2012, 64, 6
  25. 25
    William P. Arend, Gary S. Firestein, Pre-rheumatoid arthritis: predisposition and transition to clinical synovitis, Nature Reviews Rheumatology, 2012, 8, 10, 573

    CrossRef